Obstructive sleep apnea (OSA) and hypertension frequently coexist and together amplify cardiovascular risk, yet risk stratification in OSA remains largely centered on desaturation metrics. In this editorial, we contextualize the findings of Guo et al., who report an L-shaped association between admission hemoglobin levels and all-cause mortality among hospitalized patients with hypertensive OSA. We discuss the hypertensive OSA phenotype as a high-risk intersection of hypoxic and hemodynamic stress and emphasize arterial oxygen content—determined by both hemoglobin concentration and arterial oxygen saturation—as an integrative determinant of oxygen delivery reserve. Within this framework, reduced hemoglobin may further compromise tissue oxygen transport in an already vulnerable population. We underscore that hemoglobin should be interpreted as a risk modulator rather than a direct therapeutic target, and that causal inference cannot be drawn from observational data. Future prospective studies integrating polysomnographic metrics with longitudinal hemoglobin assessments are needed to clarify the clinical implications.
Bülent Özlek (Thu,) studied this question.